Rohit Loomba, MD, Named Chief of the Division of Gastroenterology and Hepatology
June 13, 2023
Loomba will lead the division at UC San Diego School of Medicine, building upon a team that shines a light on UC San Diego Health’s tripartite mission.
Your search for “hepatology” returned 42 results
New Study Flips the Script on Liver Cancer
April 12, 2023
UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.
Clinical Trial Studying Possible New Treatment Option for Patients with NAFLD
August 23, 2023
$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.
One-Two Punch: Novel Drug Pairing Could Beat Pancreatic Cancer
June 28, 2023
UC San Diego researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial
Study: Potential New Treatment Identified for Liver Disease
June 26, 2023
Researchers with UC San Diego School of Medicine identified a potential new drug that improved liver fibrosis in patients with NASH by 27%.
Study: First-Degree Relatives of Patients with NAFLD at Risk of Liver Disease
November 1, 2022
New study identifies that first-degree relatives of patients with nonalcoholic fatty liver disease with advanced fibrosis (scarring of the liver) are at a 15% risk of developing the condition.
U.S. News & World Report: UC San Diego #1 for Gastroenterology and Hepatology Research
October 28, 2020
U.S. News & World Report named University of California San Diego School of Medicine a top global university and ranked the divisions of Gastroenterology and Hepatology #1 in the world for research.
UC San Diego Health System Opens Comprehensive Liver Clinic in Nevada
August 24, 2011
Patients in Nevada seeking care for liver disease may now access the university-level expertise of UC San Diego Health System’s Center for Hepatobiliary Disease and Abdominal Transplantation (CHAT).
Novel Cytokine Protects Mice from Colitis
August 24, 2011
Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed to the disorder. Ulcerative colitis, or inflammation of the lining of the colon, is one such condition.
New Drug Successfully Halts Fibrosis in Animal Model of Liver Disease
August 7, 2012
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
